How much is the latest price of a box of Bedaquiline Fumarate (Snaery) in 2024?

Bedaquiline fumarate (Bedaquiline) is a drug used to treat multidrug-resistant tuberculosis (MDR-TB), a type of tuberculosis that is resistant to conventional anti-tuberculosis drugs such as isoniazid and rifampicin. Bedaquiline (Snaeryx) is the first TB drug to work through a new mechanism and is the first new TB drug to be approved by the U.S. Food and Drug Administration (FDA) in the past few decades.

Bedaquiline (Sneril) is currently on the market in China and has been included in medical insurance. Patients can purchase it domestically. The price of 100mg*24 tablets is around 4,000 to 5,000 yuan. For specific prices and medical insurance reimbursement, please consult the local hospital pharmacy. The cheaper ones abroad are mainly the Russian version of the original drug. The price of 100mg*188 tablets is more than 10,000 yuan, which is much cheaper than domestically. The efficacy is exactly the same as that of the domestic bedaquiline (Snaery), which is also an original drug.

Bedaquiline (Snaery) works by inhibiting bacterialATPsynthesis. ATP (adenosine triphosphate) is the energy molecule within cells that bacteria rely on to survive and replicate. This drug inhibits the growth and reproduction of bacteria by binding to the bacterial ATP synthase (ATP synthase) and preventing the production of ATP.

The efficacy of bedaquiline (Snaery) has been confirmed in clinical trials. Studies have shown that bedaquiline (Snaery) combined with other anti-tuberculosis drugs can significantly improve the cure rate compared with traditional MDR-TB treatment regimens. However, bedaquiline (Snaery) is currently reserved as a treatment option as its efficacy and safety require further study.

Although bedaquiline (Snaery) shows potential in treatingMDR-TB, it does have some limitations and potential side effects. Among them, cardiac-related adverse reactions have caused concern, so patients require regular electrocardiogram monitoring during treatment. In addition, bedaquiline (Sneril) Issues such as long-term safety and drug resistance still require more research and monitoring.